These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32911138)

  • 1. Short-term oral corticosteroids for initial treatment of moderate-to-severe persistent asthma: A double-blind, randomized, placebo-controlled trial.
    Liang Y; Wang D; Hua D; Liao H; Chen R
    Respir Med; 2020 Oct; 172():106126. PubMed ID: 32911138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
    Ni CM; Greenstone IR; Ducharme FM
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children.
    Gibson PG; Powell H; Ducharme F
    Cochrane Database Syst Rev; 2005 Oct; 2005(4):CD005076. PubMed ID: 16235393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
    Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.
    Eltonsy S; Forget A; Beauchesne MF; Blais L
    J Allergy Clin Immunol; 2015 Jan; 135(1):123-30. PubMed ID: 25226849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED).
    Gappa M; Zachgo W; von Berg A; Kamin W; Stern-Sträter C; Steinkamp G;
    Pediatr Pulmonol; 2009 Nov; 44(11):1132-42. PubMed ID: 19824054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids.
    Ahmad S; Kew KM; Normansell R
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011306. PubMed ID: 26089258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis.
    Sobieraj DM; Weeda ER; Nguyen E; Coleman CI; White CM; Lazarus SC; Blake KV; Lang JE; Baker WL
    JAMA; 2018 Apr; 319(14):1485-1496. PubMed ID: 29554195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Step-Down Therapy for Asthma Well Controlled on Inhaled Corticosteroid and Long-Acting Beta-Agonist: A Randomized Clinical Trial.
    Rogers L; Sugar EA; Blake K; Castro M; Dimango E; Hanania NA; Happel KI; Peters SP; Reibman J; Saams J; Teague WG; Wise RA; Holbrook JT;
    J Allergy Clin Immunol Pract; 2018; 6(2):633-643.e1. PubMed ID: 28974349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post hoc analysis of initial treatments and control status in the INITIAL study: an observational study of newly diagnosed patients with asthma.
    Lin J; Fu X; Jiang P; Song W; Hu X; Jie Z; Liu C; He Z; Zhou X; Tang H
    BMC Pulm Med; 2020 Apr; 20(1):87. PubMed ID: 32272921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Montelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial).
    Keith PK; Koch C; Djandji M; Bouchard J; Psaradellis E; Sampalis JS; Schellenberg RR; McIvor RA
    Can Respir J; 2009; 16 Suppl A(Suppl A):17A-31A. PubMed ID: 19557208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink.
    Ali AK; Hartzema AG; Winterstein AG; Segal R; Lu X; Hendeles L
    Value Health; 2015 Mar; 18(2):260-70. PubMed ID: 25773561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial.
    Lee LA; Bailes Z; Barnes N; Boulet LP; Edwards D; Fowler A; Hanania NA; Kerstjens HAM; Kerwin E; Nathan R; Oppenheimer J; Papi A; Pascoe S; Brusselle G; Peachey G; Sule N; Tabberer M; Pavord ID
    Lancet Respir Med; 2021 Jan; 9(1):69-84. PubMed ID: 32918892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting β
    Devillier P; Humbert M; Boye A; Zachgo W; Jacques L; Nunn C; West S; Nicholls A; Antoun Z; Spinu L; Grouin JM
    Respir Med; 2018 Aug; 141():111-120. PubMed ID: 30053956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial.
    Wenzel S; Castro M; Corren J; Maspero J; Wang L; Zhang B; Pirozzi G; Sutherland ER; Evans RR; Joish VN; Eckert L; Graham NM; Stahl N; Yancopoulos GD; Louis-Tisserand M; Teper A
    Lancet; 2016 Jul; 388(10039):31-44. PubMed ID: 27130691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma.
    Menzies-Gow A; Ponnarambil S; Downie J; Bowen K; Hellqvist Å; Colice G
    Respir Res; 2020 Oct; 21(1):279. PubMed ID: 33087119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic effects of inhaled long-acting beta2-adrenergics (LABA) and corticosteroids (ICS) are not affected by their inhalation sequence in moderate/persistent asthma.
    Dal Negro RW; Micheletto C; Tognella S; Trevisan F; Guerriero M
    Eur Ann Allergy Clin Immunol; 2006 May; 38(5):153-7. PubMed ID: 17058847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.